tiprankstipranks
Sana Biotechnology EVP and President of R&D Resigns
Company Announcements

Sana Biotechnology EVP and President of R&D Resigns

Don't Miss our Black Friday Offers:

Sana Biotechnology (SANA) just unveiled an announcement.

Douglas Williams, Ph.D., has voluntarily resigned from his roles as Executive Vice President and President of Research and Development at Sana Biotechnology, Inc., effective April 18, 2024. His departure is for personal reasons and does not stem from any disputes with the company.

See more insights into SANA stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyClimb Bio appoints Williams as Chair of the board of directors
TipRanks Auto-Generated NewsdeskSana Biotechnology, Inc. Reports Q3 2024 Financial Results
TheFlySana Biotechnology reports Q3 EPS (27c), consensus (25c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App